The Department of Health today (June 9) ordered GlaxoSmithKline Limited to recall from its consumers an antibiotic manufactured in France for paediatric patients, Augmentin powder for syrup 156mg/5ml (HK-24658), as the detection of a plasticiser, Diisodecyl phthalate (DIDP) has raised both safety and quality concerns.   Close